Locations:
Search IconSearch

Cleveland Clinic Performs World’s First DBS Surgery for Stroke Recovery

Patient doing well, stimulation to start in coming weeks

twitter-170104-17-neu-504-machado-650×450

Cleveland Clinic has performed the first deep brain stimulation (DBS) surgery in a patient for the purpose of restoring motor function following ischemic stroke.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

During a six-hour procedure on Dec. 19, 2016, a team led by Andre Machado, MD, PhD, implanted DBS electrodes in the cerebellum of the patient, who has severe post-stroke residual hemiparesis despite previous physical therapy. The patient has been discharged home feeling well and in stable condition.

Over the next few weeks, following adequate healing and recovery from the brain surgery, the patient will undergo physical therapy. After a few weeks of rehabilitation, the DBS device connected to the implanted electrodes will be turned on as the patient continues physical therapy. The patient will be monitored and evaluated regularly to determine whether and how DBS can enhance the effects of physical therapy.

The first-in-human operation is the initial case in an NIH-supported Cleveland Clinic trial of DBS for stroke recovery detailed previously on Consult QD.

“If this research succeeds, it is a new hope for patients who have remained paralyzed after a stroke,” says Dr. Machado, Chairman of Cleveland Clinic’s Neurological Institute and a neurosurgeon specializing in neuromodulation. “It is an opportunity to allow our patients to rehabilitate and gain function and independence. Our knowledge to date shows that deep brain stimulation can help the brain reorganize and adapt beyond what physical therapy alone can do. Our study’s goal is to boost rehabilitation outcomes beyond what physical therapy alone could achieve.”

More details about this initial case in the trial are available in a new Time magazine feature. Dr. Machado (shown in the foreground of the above photo) discusses the trial’s rationale and goals in this short Consult QD video.

Advertisement

Related Articles

scan of a human brain

Study Links ANNA1/Hu-IgG Paraneoplastic Neurological Syndromes With Longer Cancer Survival

Findings may have implications for understanding the disorders’ pathophysiology

portait of Dr. Jay Alberts against decorative background with podcast icon overlay
July 16, 2026/Neurosciences/Podcast

Reshaping Research With Our New Neurological Assessment Center (Podcast)

Routine capture of standardized neuroperformance data may expand and refine investigations

woman looking concerned as she listens to a doctor speak to her

Study Offers First Characterization of Patients With Nonspecific Presentations of Multiple Sclerosis

Nearly one-fifth of such cases fulfill 2024 McDonald criteria based on biomarkers

gamma knife machine

Stereotactic Radiosurgery Shows Strong Local Control in SCLC Brain Metastases

Adequate dosing may improve outcomes in well-selected patients, large Cleveland Clinic series suggests

portrait of Dr. Robert Bermel against a decorative backdrop with podcast icon overlay
July 2, 2026/Neurosciences/Podcast

Inside Our New Neurological Assessment Center (Podcast)

Reimagining the outpatient neurological visit with routine capture of neuroperformance data

woman in white medical coat typing on a laptop in lab setting
June 30, 2026/Neurosciences/Epilepsy

Online Tool Makes It Easier to Share and Analyze Data on Epilepsy-Related Cognitive Disorders

Free portal helps researchers classify and share data using the IC-CoDE framework

woman in wheelchair being wheeled into or out of an elevator

Key Rural-Urban Differences Revealed in U.S. Post-Acute Stroke Care

Large study shows rural patients are less apt to be discharged to inpatient rehab, hampering outcomes

portrait of Dr. Jeffrey Cohen against decorative background with podcast icon overlay
June 16, 2026/Neurosciences/Podcast

The Potential of CAR T-Cell Therapy in Multiple Sclerosis (Podcast)

Updates on this fast-evolving therapeutic landscape from a leading trialist

Ad